Chat with us, powered by LiveChat
BUY TICKETS

SAVE $976 BY JAN. 8

 Speaker Profile

Ph.D., Founder and CEO, PMCDx

Biography
Dr. Sherry Dadgar, Ph.D., FACMG, is a board-certified Clinical Molecular Geneticist, entrepreneur, and precision medicine innovator focused on advancing healthcare through genomics, artificial intelligence, and digital medicine. Personalized Medicine Care Diagnostics (PMCDx) advances precision medicine by translating innovation into routine clinical practice and was recognized in 2025 by government officials for leadership in healthcare innovation.Under her leadership, PMCDx has built a comprehensive precision medicine testing ecosystem, offering focused on nephrology, oncology, cardiology, connective tissue disorders, and pharmacogenetics using top notched technologies. Dr. Dadgar serves as Clinical Assistant Professor at George Washington University, teaches NIH and NHGRI fellows, and advocates nationally for healthcare equity, reimbursement reform, and sustainable innovation in advanced diagnostics.


Talk
Closing the Kidney Diagnostic Gap in Nephrogenomics
Closing the Diagnostic Gap in Kidney Disease: Clinical Impact of RenaDx and RenaXome in Nephrogenomics


Clinical Dx Nephrogenomics Showcase:
PMCDx

Personalized Medicine Care Diagnostics (PMCDx) is advancing precision medicine by translating innovation into routine clinical practice.

 Session Abstract – PMWC 2026 Silicon Valley

Showcase Track S2 - March 4 11.00 A.M.-5.00 P.M.,Showcase Track S2 - March 5 9.15 A.M.-12.00 P.M.,Showcase Track S1 - March 6 11.30 A.M.-11.45 A.M.


The PMWC 2026 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JAN. 8TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required